Colossal Biosciences to sequence 1,600 U.S. endangered species
Colossal Biosciences will sequence the genomes of all 1,600 U.S. endangered species, creating a genetic database to aid conservation efforts like tracking inbreeding and predicting climate adaptation.
Colossal Biosciences, the company behind the push to revive the woolly mammoth, just announced it will collect and sequence the genomes of every anima
Read Full Story at Ars Technica →Why This Matters
Preserving biodiversity is no longer just an ecological concern—it’s an existential one for human survival, and this project turns that urgency into actionable science. By cataloging the genetic blueprints of every U.S. endangered species, researchers can finally quantify the hidden costs of habitat loss and climate change at the most fundamental level.
Background Context
Conservation efforts have long relied on fragmented data, with fragmented funding to match. The U.S. Endangered Species Act has protected over 1,600 species since 1973, but only a fraction have had their genomes sequenced—a gap that’s left critical gaps in understanding genetic drift and resilience.
What Happens Next
The real test will be how quickly policymakers and researchers integrate this data into recovery plans, especially for species already on the brink. Questions remain about funding stability and whether this model will scale globally.
Bigger Picture
This isn’t just about saving species—it’s about rewriting the rules of conservation for the Anthropocene. As synthetic biology advances, genomic data could soon determine which species get "de-extinction" priority or face forced adaptation strategies.
